NUZ neurizon therapeutics limited

Latest MND Webinar information on Monepantel, page-34

  1. 2,481 Posts.
    lightbulb Created with Sketch. 1570
    Thanks for the concise and systematic point by point study @kpax. Going by your analysis, CNM-Au8 is very much a work in progress, unlike our monepantel pill - which has a fast-acting and very effective role in up-regulating the autophagy process that is needed as part of the treatment of MND/ALS, and most probably of other neurodegenerative diseases and a number of cancers (the latter is already proven in the lab with 28 types of human tumours) - something PharmAust needs to highlight to the investing public. PharmAust's monepantel pill, with its proven up-regulation of the much needed autophagy process with minimal side effects, is the current global gold standard for this purpose, and fearing that some highly specialised treatment like CNM-Au8 is going to suddenly make it redundant is mistaken (or so it seems to me).

    Cheers
    Last edited by Lastly: 09/08/24
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
12.0¢
Change
-0.010(7.69%)
Mkt cap ! $59.07M
Open High Low Value Volume
12.5¢ 12.5¢ 12.0¢ $31.03K 257.2K

Buyers (Bids)

No. Vol. Price($)
4 57583 11.5¢
 

Sellers (Offers)

Price($) Vol. No.
12.5¢ 109056 3
View Market Depth
Last trade - 13.02pm 03/04/2025 (20 minute delay) ?
NUZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.